# A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems.

> **NCT07433504** · NA · RECRUITING · sponsor: **Shanghai Huihe Medical Technology Co., Ltd** · enrollment: 132 (estimated)

## Conditions studied

- Severe or Greater Tricuspid Regurgitation

## Interventions

- **DEVICE:** Experimental: Transcatheter tricuspid valve repair using the transcatheter tricuspid valve clipping system +GDMT
- **DRUG:** Guideline Directed Medical Therapy

## Key facts

- **NCT ID:** NCT07433504
- **Lead sponsor:** Shanghai Huihe Medical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2027-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433504, "A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07433504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*